These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16863443)

  • 1. The use of isotopes in the determination of absolute bioavailability of drugs in humans.
    Lappin G; Rowland M; Garner RC
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):419-27. PubMed ID: 16863443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.
    Klem B; Lappin G; Nicholson S; van de Wetering J; de Vries DE; Oosterhuis B; Garner RC
    J Clin Pharmacol; 2006 Apr; 46(4):456-60. PubMed ID: 16554454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay.
    Jiang H; Zeng J; Li W; Bifano M; Gu H; Titsch C; Easter J; Burrell R; Kandoussi H; Aubry AF; Arnold ME
    Anal Chem; 2012 Nov; 84(22):10031-7. PubMed ID: 23106420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.
    Lau CE; Ma F; Wang Y; Smith C
    Psychopharmacology (Berl); 1996 Aug; 126(3):241-8. PubMed ID: 8876024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
    Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
    Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
    Guittet C; Manso M; Burton I; Granier LA; Marçon F
    Pharm Res; 2017 Sep; 34(9):1840-1848. PubMed ID: 28577272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics.
    Lappin G; Stevens L
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1021-33. PubMed ID: 18680438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.
    Dalton JT; Yates CR; Yin D; Straughn A; Marcus SL; Golub AL; Meyer MC
    J Pharmacol Exp Ther; 2002 May; 301(2):507-12. PubMed ID: 11961050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology.
    Roosendaal J; Rosing H; Beijnen JH
    Clin Pharmacol Drug Dev; 2020 Jul; 9(5):552-559. PubMed ID: 32573110
    [No Abstract]   [Full Text] [Related]  

  • 11. The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration.
    Reed MD; Rodarte A; Blumer JL; Khoo KC; Akbari B; Pou S; Pharmd ; Kearns GL;
    J Clin Pharmacol; 2001 Dec; 41(12):1359-69. PubMed ID: 11762564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.
    Gu H; Wang J; Aubry AF; Jiang H; Zeng J; Easter J; Wang JS; Dockens R; Bifano M; Burrell R; Arnold ME
    Anal Chem; 2012 Jun; 84(11):4844-50. PubMed ID: 22540405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study.
    Yuan L; Huang C; Liu-Kreyche P; Voronin K; Fancher RM; Allentoff A; Zheng N; Iyer R; Zhu L; Pillutla R; Ji QC
    J Pharm Biomed Anal; 2019 Feb; 165():198-206. PubMed ID: 30553110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.
    Nishimura T; Amano N; Kubo Y; Ono M; Kato Y; Fujita H; Kimura Y; Tsuji A
    Drug Metab Dispos; 2007 Aug; 35(8):1275-84. PubMed ID: 17470527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers.
    Sarapa N; Hsyu PH; Lappin G; Garner RC
    J Clin Pharmacol; 2005 Oct; 45(10):1198-205. PubMed ID: 16172185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding value through accelerator mass spectrometry-enabled first in human studies.
    Seymour MA
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):640-647. PubMed ID: 27444819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
    Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
    Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers.
    Lappin G
    J Clin Pharmacol; 2016 Jan; 56(1):11-23. PubMed ID: 26073308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.